The COVID-19 Vaccine Won’t Solve All Our Problems
As schools reopen many are eager for the arrival of a vaccine for COVID-19.
Tweet
Back
The end of the coronavirus may be closer than most realize. Many have waited eagerly for any form of medicine or treatment, but a vaccine seems to be the most effective way to stop the spread of COVID-19.
A vaccination gives an individual immunity to a disease by administering a small and/or weakened version of the virus that causes the disease. Theoretically, if everyone were vaccinated, immunity would be widespread. Cases and deaths would lower nationwide and it could possibly end the virus for good.
Unfortunately, not everyone is willing to take the rushed vaccine. A survey found that only 34% of Americans would willingly get an FDA approved COVID-19 vaccine as soon as it came out.
While many are reluctant, the majority of health professionals advise that vaccines are our best option because it prevents infection from happening in the first place instead of just treating the disease.
As far as progress goes for the vaccine, there are currently 170 vaccines being tracked by the World Health Organization. 7 of which are in “Phase 3” testing, one step before their approval. But approval doesn’t mean the virus is gone; the vaccine still has to be distributed.
Now, accounting for all this information the vaccine will be done anywhere from late 2020 to early 2021. Vaccinations will most likely be distributed by prioritization to health care workers and the elderly. So for the kids, they might have to wait a few months.
A vaccine may not be readily available for some time so it is important we take other measures to contain COVID-19. A recent senate interview with the head of the CDC insisted that masks are better at preventing individual cases than some vaccines in phase 3.
While many are eager to return to their “normal lives,” we need to realize this will all happen in time. For now, we need to recognize our current reality and focus on what we can do to stop the spread to save lives.
A vaccination gives an individual immunity to a disease by administering a small and/or weakened version of the virus that causes the disease. Theoretically, if everyone were vaccinated, immunity would be widespread. Cases and deaths would lower nationwide and it could possibly end the virus for good.
Unfortunately, not everyone is willing to take the rushed vaccine. A survey found that only 34% of Americans would willingly get an FDA approved COVID-19 vaccine as soon as it came out.
While many are reluctant, the majority of health professionals advise that vaccines are our best option because it prevents infection from happening in the first place instead of just treating the disease.
As far as progress goes for the vaccine, there are currently 170 vaccines being tracked by the World Health Organization. 7 of which are in “Phase 3” testing, one step before their approval. But approval doesn’t mean the virus is gone; the vaccine still has to be distributed.
Now, accounting for all this information the vaccine will be done anywhere from late 2020 to early 2021. Vaccinations will most likely be distributed by prioritization to health care workers and the elderly. So for the kids, they might have to wait a few months.
A vaccine may not be readily available for some time so it is important we take other measures to contain COVID-19. A recent senate interview with the head of the CDC insisted that masks are better at preventing individual cases than some vaccines in phase 3.
While many are eager to return to their “normal lives,” we need to realize this will all happen in time. For now, we need to recognize our current reality and focus on what we can do to stop the spread to save lives.
B-Line
B-Line students write articles that capture what it means to be part of the Barstow community, and record, review and analyze current events.
B-Line's origins date back to 1897, when students published "The School Paper," from Barstow's Quality Hill campus. It was published under various names in following decades, including "The Cornpatch," when Barstow moved to State Line in 1961. Today, B-Line is primarily a digital publication.
B-Line's origins date back to 1897, when students published "The School Paper," from Barstow's Quality Hill campus. It was published under various names in following decades, including "The Cornpatch," when Barstow moved to State Line in 1961. Today, B-Line is primarily a digital publication.
“Success in any line of work demands one know how to communicate with others concisely and persuasively.”
Adviser
List of 1 members.
Staff
List of 1 items.
-
Editors & Writers
Avani Lakkireddy
Quinn Luce
Vineeth Mothe
Charlotte Park
Amrit Siam
Finnian Waldron
